San Francisco startup Composition Therapeutics can be focusing on an oral, when-day by day GLP-one drug identified as GSBR-1290—the drug surpassed Wall Avenue’s expectations in June every time a mid-stage examine showed average weight loss of around 6% and it programs to start One mo